Kinder Morgan Inc vs TransMedics Group Inc — how do they compare? Kinder Morgan Inc trades at $32.47 (market cap $72.48B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Kinder Morgan Inc is far larger — about 28.5× TransMedics Group Inc's market cap, and Kinder Morgan Inc pays a 3.61% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| KMI | TMDX | |
|---|---|---|
Market Cap | $72.48B | $2.54B |
Sector | Energy | Technology |
52-Week High | $34.31 | $150.42 |
52-Week Low | $25.84 | $61.99 |
Enterprise Value | $104.36B | $2.94B |
Dividend Yield | 3.61% | — |
Signals from Pluang's Aura AI — not financial advice
Kinder Morgan (KMI) trades at $32.38, up 0.25% for the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q1 2026 earnings, beating estimates with EPS of $0.48 versus $0.3959 expected, and revenue growth of 13.8% year-over-year. Analyst sentiment is mixed with 47% buy ratings, while the stock offers a dividend yield supported by stable cash flows from fee-based contracts.
KMI's outlook is supported by a $10.1 billion project backlog focused on natural gas infrastructure, rising LNG exports, and power demand. Risks include exposure to energy commodity volatility and high debt levels. The stock presents a value opportunity for income investors seeking stable dividends, but requires monitoring of execution on growth projects and energy market conditions.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →